Antisense inhibition of angiotensinogen attenuates vasopressin release in the paraventricular hypothalamic nucleus of spontaneously hypertensive rats

Shuntaro Kagiyama, Takuya Tsuchihashi, Isao Abe, Kiyoshi Matsumura, Masatoshi Fujishima

研究成果: ジャーナルへの寄稿記事

9 引用 (Scopus)

抄録

It has been reported that intracerebroventricularly injected antisense oligonucleotide to angiotensinogen reduces arterial pressure in spontaneously hypertensive rats (SHR), but the mechanism and the sites of action remain unclear. In the present study, we examined whether injection of antisense oligonucleotide to angiotensinogen into the paraventricular hypothalamic nucleus (PVN) would influence arterial pressure and vasopressin release. For this purpose, 12-week-old male SHR were cannulated into the bilateral PVN. One week later, we injected antisense or sense oligonucleotide to angiotensinogen into the bilateral PVN (0.2 nmol/200 nl each side). After 24 h, we directly monitored arterial pressure, and then took blood samples to measure plasma vasopressin, catecholamines and renin activity. Mean arterial pressure did not change in either group (from 144 ± 3 to 154 ± 4 mmHg for the antisense oligonucleotide group, n = 11; from 147 ± 4 to 156 ± 3 mmHg for the sense oligonucleotide group, n = 11). Antisense oligonucleotide attenuated vasopressin release compared with sense oligonucleotide (1.30 ± 0.28 vs. 3.29 ± 0.60 pg/ml, respectively, P < 0.01). Plasma catecholamines also decreased in the antisense oligonucleotide group compared with the sense oligonucleotide group. However, the plasma renin activity did not differ between the groups. In the additional experiment, we examined the neurohormonal and cardiovascular effects of intracerebroventricularly injected antisense oligonucleotide to angiotensinogen in SHR. Mean arterial pressure, plasma vasopressin and plasma norepinephrine were significantly lower in the antisense oligonucleotide group than in the sense oligonucleotide group. These results suggest that angiotensinogen in PVN plays important roles in vasopressin release and sympathetic nerve activity, but may not contribute to the maintenance of arterial pressure in SHR.

元の言語英語
ページ(範囲)120-124
ページ数5
ジャーナルBrain Research
829
発行部数1-2
DOI
出版物ステータス出版済み - 5 22 1999

Fingerprint

Angiotensinogen
Paraventricular Hypothalamic Nucleus
Antisense Oligonucleotides
Inbred SHR Rats
Vasopressins
Arterial Pressure
Oligonucleotides
Renin
Catecholamines
Norepinephrine
Maintenance
Injections

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)
  • Molecular Biology
  • Clinical Neurology
  • Developmental Biology

これを引用

Antisense inhibition of angiotensinogen attenuates vasopressin release in the paraventricular hypothalamic nucleus of spontaneously hypertensive rats. / Kagiyama, Shuntaro; Tsuchihashi, Takuya; Abe, Isao; Matsumura, Kiyoshi; Fujishima, Masatoshi.

:: Brain Research, 巻 829, 番号 1-2, 22.05.1999, p. 120-124.

研究成果: ジャーナルへの寄稿記事

Kagiyama, Shuntaro ; Tsuchihashi, Takuya ; Abe, Isao ; Matsumura, Kiyoshi ; Fujishima, Masatoshi. / Antisense inhibition of angiotensinogen attenuates vasopressin release in the paraventricular hypothalamic nucleus of spontaneously hypertensive rats. :: Brain Research. 1999 ; 巻 829, 番号 1-2. pp. 120-124.
@article{bf7dee36f7fa4788a419a9ca0f788ea5,
title = "Antisense inhibition of angiotensinogen attenuates vasopressin release in the paraventricular hypothalamic nucleus of spontaneously hypertensive rats",
abstract = "It has been reported that intracerebroventricularly injected antisense oligonucleotide to angiotensinogen reduces arterial pressure in spontaneously hypertensive rats (SHR), but the mechanism and the sites of action remain unclear. In the present study, we examined whether injection of antisense oligonucleotide to angiotensinogen into the paraventricular hypothalamic nucleus (PVN) would influence arterial pressure and vasopressin release. For this purpose, 12-week-old male SHR were cannulated into the bilateral PVN. One week later, we injected antisense or sense oligonucleotide to angiotensinogen into the bilateral PVN (0.2 nmol/200 nl each side). After 24 h, we directly monitored arterial pressure, and then took blood samples to measure plasma vasopressin, catecholamines and renin activity. Mean arterial pressure did not change in either group (from 144 ± 3 to 154 ± 4 mmHg for the antisense oligonucleotide group, n = 11; from 147 ± 4 to 156 ± 3 mmHg for the sense oligonucleotide group, n = 11). Antisense oligonucleotide attenuated vasopressin release compared with sense oligonucleotide (1.30 ± 0.28 vs. 3.29 ± 0.60 pg/ml, respectively, P < 0.01). Plasma catecholamines also decreased in the antisense oligonucleotide group compared with the sense oligonucleotide group. However, the plasma renin activity did not differ between the groups. In the additional experiment, we examined the neurohormonal and cardiovascular effects of intracerebroventricularly injected antisense oligonucleotide to angiotensinogen in SHR. Mean arterial pressure, plasma vasopressin and plasma norepinephrine were significantly lower in the antisense oligonucleotide group than in the sense oligonucleotide group. These results suggest that angiotensinogen in PVN plays important roles in vasopressin release and sympathetic nerve activity, but may not contribute to the maintenance of arterial pressure in SHR.",
author = "Shuntaro Kagiyama and Takuya Tsuchihashi and Isao Abe and Kiyoshi Matsumura and Masatoshi Fujishima",
year = "1999",
month = "5",
day = "22",
doi = "10.1016/S0006-8993(99)01375-X",
language = "English",
volume = "829",
pages = "120--124",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Antisense inhibition of angiotensinogen attenuates vasopressin release in the paraventricular hypothalamic nucleus of spontaneously hypertensive rats

AU - Kagiyama, Shuntaro

AU - Tsuchihashi, Takuya

AU - Abe, Isao

AU - Matsumura, Kiyoshi

AU - Fujishima, Masatoshi

PY - 1999/5/22

Y1 - 1999/5/22

N2 - It has been reported that intracerebroventricularly injected antisense oligonucleotide to angiotensinogen reduces arterial pressure in spontaneously hypertensive rats (SHR), but the mechanism and the sites of action remain unclear. In the present study, we examined whether injection of antisense oligonucleotide to angiotensinogen into the paraventricular hypothalamic nucleus (PVN) would influence arterial pressure and vasopressin release. For this purpose, 12-week-old male SHR were cannulated into the bilateral PVN. One week later, we injected antisense or sense oligonucleotide to angiotensinogen into the bilateral PVN (0.2 nmol/200 nl each side). After 24 h, we directly monitored arterial pressure, and then took blood samples to measure plasma vasopressin, catecholamines and renin activity. Mean arterial pressure did not change in either group (from 144 ± 3 to 154 ± 4 mmHg for the antisense oligonucleotide group, n = 11; from 147 ± 4 to 156 ± 3 mmHg for the sense oligonucleotide group, n = 11). Antisense oligonucleotide attenuated vasopressin release compared with sense oligonucleotide (1.30 ± 0.28 vs. 3.29 ± 0.60 pg/ml, respectively, P < 0.01). Plasma catecholamines also decreased in the antisense oligonucleotide group compared with the sense oligonucleotide group. However, the plasma renin activity did not differ between the groups. In the additional experiment, we examined the neurohormonal and cardiovascular effects of intracerebroventricularly injected antisense oligonucleotide to angiotensinogen in SHR. Mean arterial pressure, plasma vasopressin and plasma norepinephrine were significantly lower in the antisense oligonucleotide group than in the sense oligonucleotide group. These results suggest that angiotensinogen in PVN plays important roles in vasopressin release and sympathetic nerve activity, but may not contribute to the maintenance of arterial pressure in SHR.

AB - It has been reported that intracerebroventricularly injected antisense oligonucleotide to angiotensinogen reduces arterial pressure in spontaneously hypertensive rats (SHR), but the mechanism and the sites of action remain unclear. In the present study, we examined whether injection of antisense oligonucleotide to angiotensinogen into the paraventricular hypothalamic nucleus (PVN) would influence arterial pressure and vasopressin release. For this purpose, 12-week-old male SHR were cannulated into the bilateral PVN. One week later, we injected antisense or sense oligonucleotide to angiotensinogen into the bilateral PVN (0.2 nmol/200 nl each side). After 24 h, we directly monitored arterial pressure, and then took blood samples to measure plasma vasopressin, catecholamines and renin activity. Mean arterial pressure did not change in either group (from 144 ± 3 to 154 ± 4 mmHg for the antisense oligonucleotide group, n = 11; from 147 ± 4 to 156 ± 3 mmHg for the sense oligonucleotide group, n = 11). Antisense oligonucleotide attenuated vasopressin release compared with sense oligonucleotide (1.30 ± 0.28 vs. 3.29 ± 0.60 pg/ml, respectively, P < 0.01). Plasma catecholamines also decreased in the antisense oligonucleotide group compared with the sense oligonucleotide group. However, the plasma renin activity did not differ between the groups. In the additional experiment, we examined the neurohormonal and cardiovascular effects of intracerebroventricularly injected antisense oligonucleotide to angiotensinogen in SHR. Mean arterial pressure, plasma vasopressin and plasma norepinephrine were significantly lower in the antisense oligonucleotide group than in the sense oligonucleotide group. These results suggest that angiotensinogen in PVN plays important roles in vasopressin release and sympathetic nerve activity, but may not contribute to the maintenance of arterial pressure in SHR.

UR - http://www.scopus.com/inward/record.url?scp=0033594740&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033594740&partnerID=8YFLogxK

U2 - 10.1016/S0006-8993(99)01375-X

DO - 10.1016/S0006-8993(99)01375-X

M3 - Article

C2 - 10350537

AN - SCOPUS:0033594740

VL - 829

SP - 120

EP - 124

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 1-2

ER -